Allergy/Asthma News

SAN DIEGO — While it did not perform at the level of clinicians, ChatGPT could be used as a tool to improve patch testing efficiency for allergic contact dermatitis, according to a poster presentation here.

In our last post, we saw how rollover equity fits into the overall consideration paid to a selling physician owner of a physician practice.

Spring is upon us in the Northern Hemisphere, and many patients are experiencing classic “hay fever” symptoms including itch, stuffy nose, sneezing and rash as well as eye symptoms.

Babies born during the lockdown of March through May 2020 developed significant differences in their microbiome and less atopic dermatitis compared with babies born prior to this period, according to a study published in Allergy.

WASHINGTON — Patients with chronic spontaneous urticaria experienced better quality of life with dupilumab compared with placebo, according to two posters presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The first patient has been dosed in Jasper Therapeutic’s phase 1b/2a SPOTLIGHT clinical trial of subcutaneous briquilimab for the treatment of chronic inducible urticaria, the company announced in a press release.

Patients who believe they have allergic rhinitis really might have chronic rhinosinusitis, according to a study published in Otolaryngology – Head and Neck Surgery.

As practice management demands pull clinicians away from their patients to tend to administrative responsibilities, digital technologies are stepping in to mitigate these burdens. But keeping up with new tech can be a chore by itself.

The U.S. Environmental Protection Agency has finalized stricter limits on emissions from model year 2027 through 2032 passenger cars, light-duty trucks and medium-duty vehicles, according to a press release from the agency.

After spending 17 years working as an allergist in Alaska, Melinda M. Rathkopf, MD, MBA, made a big career change in 2023.